Validation of guinea pig model of allergic rhinitis by oral and topical drugs

International Immunopharmacology

Volumn 8, Issue 11, 2008, Pages 1540-1551

  Bahekar, Prashant C ^a   Shah, Jigar H ^a   Ayer, Upendra B ^a   Mandhane, Sanjay N ^a   Thennati, Rajamannar ^a  

^a Sun Pharma Advanced Research Company Limited   (India)

Author keywords

Allergic rhinitis; Guinea pig; Ovalbumin

Indexed keywords

AZELASTINE; CETIRIZINE; CROMOGLYCATE DISODIUM; DESLORATADINE; DEXAMETHASONE; EPINASTINE; FEXOFENADINE; FLUTICASONE; IMMUNOGLOBULIN G; INDOMETACIN; IPRAMIST; IPRATROPIUM BROMIDE; MIZOLASTINE; MONTELUKAST; NASIVION; OLOPATADINE; OVALBUMIN; OXYMETAZOLINE; PREDNISOLONE; RUPATADINE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG EFFICACY; FEMALE; GUINEA PIG; HISTOPATHOLOGY; LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; SNEEZING; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-ALLERGIC AGENTS; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; HUMIDITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; MALE; OVALBUMIN; PASSIVE CUTANEOUS ANAPHYLAXIS; RHINITIS, ALLERGIC, PERENNIAL; SNEEZING;

EID: 51749118444     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.06.010     Document Type: Article

References (52)

1. Lee N.P., and Arriola E.R. How to treat allergic rhinitis. Best Practice 171 (1999) 31-34
2. Prenner B.M., and Schenkel E. Allergic rhinitis: treatment based on patients profiles. Am J Med 119 (2006) 230-237
3. Quraishi S.A., Davies M.J., and Craig T.J. Inflammatory responses in allergic rhinitis: traditional approaches and novel treatment strategies. J Am Osteopath Assoc 104 (2004) S7-15
4. 1 receptor antagonist. Immunopharmacology 48 (2000) 1-7
5. Nabe T., Shimizu K., Mizutani N., Saeki Y., Yamamura H., Takenaka H., et al. A new model of experimental allergic rhinitis using Japanese cedar pollen in guinea pigs. Jpn J Pharmacol 75 (1997) 243-251
6. Nabe T., Mizutani N., Osakai S., Sugahara S., Takinaka H., and Kohno S. Comparison of cedar pollen-induced allergic rhinitis in passively and actively sensitized guinea pigs. Jpn J Pharmacol 85 (2001) 409-415
7. 2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis. Inflamm Res 50 (2001) 466-473
8. Wang D., Smitz J., Waterschoot S., and Clement P. An approach to the understanding of the nasal early phase reaction induced by nasal allergen challenge. Allergy 52 (1997) 162-167
9. Mizuno H., Iwase N., Kawamura Y., Ohno H., Hosokawa T., and Kasuya Y. Effects of muscarinic antagonists on experimental nasal secretion in guinea pigs. Jpn J Pharmacol 55 (1991) 531-537
10. Kaise T., Akamtsu Y., Ohmori K., Ishii A., and Karasawa A. Inhibitory effect of olopatadine hydrochloride on the sneezing response induced by intranasal capsaicin challenge in guinea pigs. Jpn J Pharmacol 86 (2001) 258-261
11. Al Suleimani M., Ying D., and Walker M.J. A comprehensive model of allergic rhinitis in guinea pigs. J Pharmacol Toxicol Methods 55 (2007) 127-134
12. Nabe T., Mizutani N., Shimizu K., Takinaka H., and Kohno S. Development of pollen-induced allergic rhinitis with early and late phase nasal blockage in guinea pigs. Inflamm Res 47 (1998) 369-374
13. Underwood S., Foster M., Raeburn D., Bottoms S., and Karlsson J.A. Time-course of antigen induced airway inflammation in the guinea pig and its relationship to airway hyperresponsiveness. Eur Respir J 8 (1995) 2104-2113
14. Mizutani N., Nabe T., Takinaka H., and Kohno S. Acquired nasal hyperresponsiveness aggravates antigen-induced rhinitis in the guinea pig. J Pharmacol Sci 93 (2003) 437-445
15. Brozmanova M., Calkovsky V., Plevkova J., Bartos V., Plank L., and Tatar M. Early and late allergic phase related cough response in sensitized guinea pigs with experimental allergic rhinitis. Physiol Res 55 (2006) 577-584
16. Iijima H., Tamura G., Hsiue T., Liu Y., Taniguchi, and Shirato K. Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs. Am J Respir Crit Care Med 160 (1999) 331-335
17. Yamasaki M., Sasaki K., Mizutani N., Nabe T., Sakura Y., Matsumoto T., et al. Pharmacological characterization of the leukocyte kinetics after intranasal antigen challenge in a guinea pig model of allergic rhinitis. Inflamm Res 50 (2001) 474-482
18. Dai Y., Lin-Jun F.u., Wang Z.D., and Zhang M. Inhibition of experimental allergic rhinitis by the n-butanol fraction from the anomalous fruits of Gleditsia sinensis. Biol Pharmaceut Bull 26 (2003) 974-977
19. Baroody F.M., Assanasen P., Chung J., and Naclerio R.M. Hot, humid air partially inhibits the nasal response to allergen provocation. Arch Otolaryngol Head Neck Surg 126 (2000) 749-754
20. Assanasen P., Baroody F.M., Naureckas E., and Naclerio R.M. Hot, humid air increases cellular influx during the late phase response to nasal challenge with antigen. Clin Exp Allergy 31 (2001) 1913-1922
21. Desrosiers M., Proud D., and Naclerio R.M. Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhino Laryngol 105 (1996) 146-154
22. Barbet J.P., Chauveau M., Labbe S., and Lockhart A. Breathing dry air causes epithelial damage and inflammation of guinea pig trachea. J Appl Physiol 64 (1988) 1851-1857
23. Ohtsuka A., Koyama S., and Horie T. Influence of airway temperature and humidity of hyperventilation induced bronchoconstriction in rabbits. Arerugi 42 (1993) 864-869
24. Kaise T., Akamatsu Y., and Ohmori K. Effect of oxatomide on experimental allergic rhinitis in guinea pigs. Jpn J Pharmacol 76 (1998) 222-226
25. 1-receptor antagonist: desloratadine, the model paradigm. Clin Drug Invest 25 (2005) 153-164
26. Zhao Y., John K.S., Leung P.C., Chen G.G., Wong Y.O., Liu S.X., et al. Symptomatic and pathophysiological observations in a modified animal model of allergic rhinitis. Rhinology 43 (2005) 47-54
27. Van C.P., and Wang D. Antihistamines and nasal blockage. Allergy 52 (1997) 35-38
28. Manuel M., Marta G., Dolors B., Rosa F., Mireia Q., Anna P., et al. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther 280 (1996) 114-121
29. Masahiko T., Motokazu N., and Hidemi N. Distribution to the skin of epinastine hydrochloride in atopic dermatitis patients. Eur J Dermatol 17 (2007) 33-36
30. 2 and histamine in experimental allergic rhinitis in guinea pigs. J Pharmacol Exp Ther 280 (1997) 1471-1479
31. 2 in antigen-induced nasal blockage in guinea pigs. Int Arch Allergy Immunol 112 (1997) 400-405
32. 1 receptor antagonists on compound 48/80-induced scratching behaviour in mice. Eur J Pharmacol 351 (1998) 1-5
33. Barnes P.J. Anti-inflammatory action of glucocorticoids: molecular mechanisms. Clin Sci 94 (1998) 557-572
34. Alan R., David M., Drazen J.M., Rabe K.F., Peter S.P., and Naclerio R.M. Immunobiology of asthma and rhinitis. Am J Crit Care Med 160 (1999) 1778-1789
35. Williams J.M. Mechanism of allergy and chemical sensitivity. Toxicol Ind Health 15 (1999) 331-338
36. Godthelp T., Holm A.F., Blom H., Klein-Jan A., Rijntjes E., and Fokkens W.J. The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammation in perennial allergic rhinitis. Allergy 50 (1995) 21-24
37. McNeely W., and Wiseman L. Intranasal azelastine. Drugs 56 (1998) 91-114
38. Kawabata K., Fujita M., Yonetomi Y., Takeda H., Nakagawa N., and Ohno H. Effect of specific cysteinyl leukotriene antagonist, pranlukast, on antigen-induced cysteinyl leukotriene-mediated rhinitis in guinea pigs. Jpn J Pharmacol 75 (1997) 347-353
39. Kaise T., Ohmori K., Sasaki Y., and Ukai K. The effect of KW-4679, antiallergic drugs, on experimental allergic rhinitis in guinea pigs: effect on nasal blockage. Jpn J Pharmacol 69 (1995) 435-438
40. Miyake K., Horikoshi K., Ikeda Y., Ishii A., and Karasawa A. Effect of olopatadine hydrochloride on increase of histamine and peptide-leukotrienes concentration in nasal lavage fluid following the antigen-antibody reaction in actively sensitized guinea pigs. Jpn J Pharmacol 85 (2001) 453-456
41. Shelton D., and Eiser N. Histamine receptor in human nose. Clin Otolaryngol 19 (1994) 45-49
42. 3 receptor blockade produced nasal congestion in experimental model of nasal congestion. Am J Rhinol 13 (1999) 391-399
43. Kamei C., Ishizawa K., Saitou K., Suzuki G., Tarumi T., Nakahara H., et al. Effect of mometasone furoate by topical application on allergic rhinitis model in rats. Pharmacology 61 (1999) 91-95
44. Kamei C., Sugimoto Y., Kakinoki H., Izumo T., and Ichiki C. Effect of mometasone furoate on experimental allergic rhinitis in rats. Jpn Pharmacol Ther 23 (1995) 2979-2982
45. Wagner J.G., and Harkema J.R. Rodent models of allergic rhinitis: relevance to human pathophysiology. Curr Allergy Asthma Rep 7 (2007) 134-140
46. Ikejiri Y., Ogawa T., Tokumochi F., Sameshima S., and Kimura M. Antiallergic composition for ophthalmic or nasal use (1994) EP0605203
47. Howarth P.H. Leukotrienes in rhinitis. Am J Respir Crit Care Med 161 (2000) 133-136
48. 4) antagonist ICI 204,219 relieves ragweed allergic rhinitis symptoms. J Allergy Clin Immunol 91 (1993) 259
49. Renzi P.M. Antileukotriene agents in asthma: the dart that kills the elephant. Can Med Assoc J 160 (1999) 217-223
50. White M.V., and Kaliner M.A. Mediators of allergic rhinitis. J Allergy Clin Immunol 52 (1992) 33-40
51. Gupta U., and Rewari S. Modification of antihistaminic activity of cetirizine by nimesulide. J Asso Phy Ind 47 (1999) 389-392
52. Georgitis J.W. The anticholinergic treatment of allergic perennial rhinitis. J Allergy Clin Immunol 90 (1992) 1071-1076